Black phosphorus (BP) is one of the emerging versatile nanomaterials with outstanding
biocompatibility and biodegradability, exhibiting great potential as a promising inorganic …

Cancer patients with low or absent pre-existing anti-tumour immunity (“cold” tumours)
respond poorly to treatment with immune checkpoint inhibitors (ICPI). In order to render …

Photodynamic therapy (PDT) causes selective damage to tumor cells and vasculature and
also triggers an anti-tumor immune response. The latter fact has prompted the exploration of …

Several breakthroughs have been achieved in anti-tumor immune checkpoint blockade
(ICB) therapy in the past decade. Despite the considerable therapeutic effects, ICB is still …

Modulating the tumor immune microenvironment to activate immune cells has been
investigated to convert cold to hot tumors. Here, we report that metal–lipid hybrid …

Colorectal cancer (CRC) is a lethal malignancy with a high mortality rate due to its low
immunogenicity, the strong immunosuppressive milieu and poor drug permeability. To …

Chronic pain remains a major problem worldwide, despite the availability of various non-
pharmacological and pharmacological treatment options. Therefore, new analgesics with …

Despite the great achievements of immune checkpoint blockade (ICB) therapy on
programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) axis, ICB …

Background We previously demonstrated potent antitumor activity against human breast
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …

Despite great strides in anticancer research, performance statistics of current treatment
modalities remain dismal, highlighting the need for safe, efficacious strategies for tumour …